Annual report pursuant to Section 13 and 15(d)

Equity-Based Compensation (Tables)

v3.8.0.1
Equity-Based Compensation (Tables)
 12 Months Ended
Dec. 30, 2017
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Schedule Of Remaining Unrecognized Compensation Expense For Unvested Awards



 

 



 

 

2018

 

$         14,071

2019

 

 10,393 

2020

 

 4,597 

2021

 

 2,680 



 

$         31,741



 

 

The cost above is expected to be recognized over a weighted-average period of 2.87 years.

 

 



 

 



Stock-Settled Stock Appreciation Rights [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Schedule Of Fair Value Assumptions



 

 

 

 

 

 

 

 



 

 

 

 

 

 

 

 



 

Year ended

 

 



 

 

 

 

 

 

 

 



 

2015

 

2016

 

2017

 

 



 

 

 

 

 

 

 

 

Expected volatility (1)

 

 44.0% 

 

 47.5% 

 

N/A

 

 

Risk-free interest rate (2)

 

 1.3% 

 

 1.1% 

 

N/A

 

 

Expected life (3)

 

3.8 yrs.

 

3.7 yrs.

 

N/A

 

 

Expected dividend yield (4)

 

 0.0% 

 

 0.0% 

 

N/A

 

 

Weighted-average exercise price (5)

 

 $67.71 

 

 $63.16 

 

N/A

 

 



 

 

 

 

 

 

 

 

(1) The Company utilizes historical volatility of the trading price of its common stock.

 

(2) Risk-free interest rate is based on the U.S. Treasury yield curve with respect to the expected life of the award.

 

(3) Depending upon the terms of the award, one of two methods will be used to calculate expected life:

 

  (i) a weighted-average that includes historical settlement data of the Company’s equity awards and a

 

  hypothetical holding period, or (ii) the simplified method.

 

(4) The Company historically has not paid and currently has no plan to pay dividends.

 

 

(5) Exercise price is the closing price of the Company's common stock on the date of grant.

 

 



 

 



Schedule Of Stock-Settled Stock Appreciation Rights Activity



 

 

 

 

 

 

 

 

 



 

Shares

 

Weighted-average exercise price

 

Weighted-average remaining contractual term

 

Aggregate intrinsic value*

 

Outstanding at December 31, 2016

 

 3,391 

 

$          54.69

 

 3.1 

 

$        36,169

 

Granted

 

 -

 

 -

 

 

 

 

 

Exercised

 

 (884)

 

 33.63 

 

 

 

 

 

Forfeited

 

 (181)

 

 55.78 

 

 

 

 

 

Expired

 

 (36)

 

 65.26 

 

 

 

 

 



 

 

 

 

 

 

 

 

 

Outstanding at December 30, 2017

 

 2,290 

 

$          62.49

 

 2.6 

 

$        26,703

 



 

 

 

 

 

 

 

 

 

Exercisable at December 30, 2017

 

 420 

 

$          53.12

 

 2.1 

 

$          8,782

 



 

 

 

 

 

 

 

 

 



 





* Aggregate intrinsic value is defined as the difference between the current market value at the reporting date (the closing price of the Company's common stock on the last trading day of the period) and the exercise price of awards that were in-the-money.  The closing price of the Company's common stock at December 31, 2016, and December 30, 2017, was $61.20 and $74.05, respectively.

Restricted Stock Units [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Schedule Of Restricted Stock Unit Activity



 

 

 

 



 

Shares

 

Weighted-average grant date fair value

Outstanding at December 31, 2016

 

 -

 

$                          -

Granted

 

 92 

 

 59.42 

Vested

 

 -

 

 -

Forfeited

 

 -

 

 -



 

 

 

 

Outstanding at December 30, 2017

 

 92 

 

$                   59.42



 

 

 

 



Deferred Stock Units [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Schedule Of Deferred Stock Unit Activity



 

 

 

 



 

Shares

 

Weighted-average grant date fair value

Nonvested at December 31, 2016

 

 5 

 

$                    61.60

Granted

 

 8 

 

 58.00 

Vested

 

 (10)

 

 59.14 

Forfeited

 

 -

 

 -



 

 

 

 

Nonvested at December 30, 2017

 

 3 

 

$                    60.24